Pfizer announced it has entered into an exclusive global collaboration and license agreement with Chongqing Yao ...
Pfizer’s recent bidding war for an obesity biotech clearly hasn’t satiated the pharma’s appetite for new GLP-1 therapies—at least going by ...
Pfizer has entered into an exclusive global collaboration and license agreement with YaoPharma for the development, ...
The licensed small-molecule GLP-1R agonists were independently researched and developed by Fosun Pharma's subsidiary Yao Pharma with proprietary intellectual property rights and are intended for the ...
KIRKLAND, QC, Aug. 19, 2025 /CNW/ - On World Humanitarian Day, Pfizer Canada is proud to mark 30 years of partnership with Health Partners International of Canada (HPIC), a collaboration that has ...
Yao Pharma's deal with the US pharmaceutical giant underscores China's growing role in global biotech licensing US ...
Pfizer Inc. (NYSE:PFE) ranks among the top picks for a retirement portfolio. BMO Capital reaffirmed its Outperform rating and $30 price target for Pfizer Inc. (NYSE:PFE) on September 23 in response to ...
New York City-based Pfizer and Russia-based NovaMedica completed a long-term strategic partnership to transfer the rights and technologies for the production of more than 30 drugs from Pfizer’s to ...
theheraldghana.com on MSN
Ghana Medical Trust Fund pursues strategic partnership with Pfizer to improve access to essential medicines
The Ghana Medical Trust Fund (GMTF) is initiating steps to get the right medication at the right time for Ghanaians. It will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback